C30H41N11O2
Neat
587.73
2280085-84-7; Tofacitinib Impurity N49
1-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-2-[[2-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-2-oxoethyl]amino]ethanone;hydrochloride
InChI=1S/C30H41N11O2.ClH/c1-19-7-11-40(15-23(19)38(3)29-21-5-9-32-27(21)34-17-36-29)25(42)13-31-14-26(43)41-12-8-20(2)24(16-41)39(4)30-22-6-10-33-28(22)35-18-37-30;/h5-6,9-10,17-20,23-24,31H,7-8,11-16H2,1-4H3,(H,32,34,36)(H,33,35,37);1H/t19-,20-,23+,24+;/m1./s1